Ayse Uysal

6PUBLICATIONS
75CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Te urupare me te whai wāhi Māori ki te mātauranga (Māori responsiveness and engaged education)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Real-World Outcomes of Belinostat in Relapsed Refractory T-Cell Lymphomas: A Report from the Lymphoma Study Group of Turkish Society of Hematology.

|Aug 27, 2026
Elranatamab in Relapsed/Refractory Multiple Myeloma: A Multicenter Real-World Study from Türkiye.

|Mar 14, 2026
Real-World Outcomes of Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease: A Multicenter Retrospective Observational Study from Turkey.

Mehmet Bakırtaş, İlhami Berber, İpek Yönal Hindilerden

|Jan 28, 2026
Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study.

Sema Seçilmiş, Sibel Kabukçu Hacıoğlu, Fehmi Hindilerden

|Oct 26, 2024
Multicentral Retrospective Analysis of Venetoclax-Based Treatments in AML and MDS: A Real-World Study by the Turkish Hematology Network Group.

Ibrahim Halil Acar, Muzeyyen Aslaner Ak, Gulsah Akyol

|Nov 14, 2023
Experience of Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multicenter Study from Türkiye

Atakan Tekinalp, Ayfer Gedük, Aydan Akdeniz

Pageof 1

Frequent Collaborators

2 joint publications

Turgay Ulaş

2 joint publications

Esra Terzi Demirsoy

2 joint publications

Sibel Kabukçu Hacıoğlu

2 joint publications

Sema Seçilmiş